Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group.
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group.
复制标题
低纯度和中纯度凝血因子治疗对先天性凝血障碍中人类免疫缺陷病毒感染进展的影响。
作者：
Gjerset,GF;Pike,MC;Mosley,JW;Hassett,J;Fletcher,MA;Donegan,E;Parker,JW;Counts,RB;Zhou,Y;Kasper,CK
